Skip to content
IP + Technology Law
Home  »  News & Insights  »  Presentation

Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Written Description and Enablement

June 13, 2022  | Jessica Achtsam, Dan Altman and Eric Furman, Ph.D.

Partner Jason Gersting, Ph.D. moderated a panel of his peers in a discussion about learning how to identify the waves in current written description and enablement law and tips for smoothly riding them to expand, enhance and protect life sciences intellectual property rights. Panelists included Knobbe Martens partners Jessica Achtsam, Eric Furman, Ph.D., and Dan Altman.

View on SlideShare: Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Written Description and Enablement

View and download the full presentation below.
Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Written Description and Enablement

View more Knobbe Martens slide presentations here.

 

 

Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Written Description and Enablement Headshot

Jessica Achtsam

Jessica Achtsam practices intellectual property law with an emphasis on U.S. and foreign patent portfolio management, IP due diligence, and competitive landscape analysis in the medical device and biotechnology fields....

Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Written Description and Enablement Headshot

Dan Altman

Daniel E. Altman focuses on patent protection and related licensing issues for the biotechnology, pharmaceutical and chemical industries. A particular specialty of Dan’s relates to foreign patent protection for these...

Surfing the Waves of US IP Trends: Tips for Smoothly Riding the Waves in Written Description and Enablement Headshot

Eric Furman, Ph.D.

Eric S. Furman, Ph.D. focuses on patent protection and other forms of intellectual property protection for biotechnology, pharmaceuticals, and medical devices. Eric’s practice includes strategic patent counseling and procurement, freedom...

Related Links

Practice Areas

News & Insights

Blog - Litigation
Jan 2025
A Patent Must Describe What Is Claimed, Not What Infringes
NOVARTIS PHARMACEUTICALS CORPORATION v. TORRENT PHARMA INC. Before Lourie, Prost, and Reyna.  Appeal from the U.S. District Court for the District of Delaware. Summary: A patent was not invalid for lack...
Publications
Jan 2025
Consider Patent and Trademark Filings This Week To Avoid New Fees
The U.S. Patent and Trademark Office typically raises its fees every few years. However, this year the Office will implement a new category of fees for patent continuations with more...
Newsletter
Jan 2025
Federal Circuit Review | December 2024
December Federal Circuit Newsletter (Japanese) December Federal Circuit Newsletter (Chinese)   Bound to Happen: Inherent Property Leaves No Question of Reasonable Expectation of Success In Cytiva Bioprocess R&D Ab v....